Dr. Sophie Dessureault’s journey through medicine has been nothing short of remarkable. Graduating with distinction from Dalhousie University School of Medicine in Halifax, Nova Scotia, she embarked on a path of excellence that has left a mark on the field of surgical oncology.
Following her passion for surgical research, Dr. Dessureault pursued a rigorous surgical residency and earned her Ph.D. through the esteemed Surgical Scientist Program at the University of Toronto. Her thirst for knowledge and dedication to her craft led her to H. Lee Moffitt Cancer Center & Research Institute in Tampa, Florida, where she completed her surgical oncology fellowship in 1999.
It was during her time at Moffitt that Dr. Dessureault became known for her pioneering work in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC). Her involvement in groundbreaking studies paved the way for advancements in treating peritoneal mesothelioma, a rare and aggressive form of cancer affecting the abdominal lining.
Dr. Dessureault has served as an esteemed associate professor at the University of South Florida’s College of Medicine, imparting her wealth of knowledge and experience to the next generation of medical professionals. Her contributions to the field have not gone unnoticed, as evidenced by her accolades, including the prestigious Society of Surgical Oncology Young Investigator Award and the American Society of Clinical Oncology Career Development Award.
Over her decades of experience, Dr. Dessureault has pushed the boundaries of surgical oncology through her research, publications, and active involvement in professional organizations such as the American Society of Clinical Oncology, Society of Surgical Oncology, Royal College of Surgeons of Canada, and Alpha Omega Alpha Honor Medical Society. Her unwavering commitment to excellence serves as an inspiration to colleagues and patients alike.
He is a devoted mother and advocate for neurodiversity and mental health.
